Literature DB >> 12597245

Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma.

Akihiko Abe1, Kazunari Sato, Tomonori Habuchi, Lizhong Wang, Zhenhua Li, Norihiko Tsuchiya, Chikara Ohyama, Shigeru Satoh, Osamu Ogawa, Tetsuro Kato.   

Abstract

We investigated native Japanese subjects whether C702T, C936T and G1612A polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor (VEGF) gene are associated with the risk of renal cell carcinoma (RCC). Genomic DNAs from 145 RCC patients and 145 healthy controls were examined by polymerase chain reaction-based restriction fragment length polymorphism. Variant allele frequencies of C702T, C936T and G1612A were 0.00, 0.20 and 0.13 in the controls, respectively. The C702T and G1612A allele frequencies were significantly different between the Japanese population and the Caucasian population reported elsewhere. For each of C936T and G1612A polymorphisms, there was no statistically significant difference in the distribution of genotype frequencies between the cases and controls. Odds ratios and 95% confidence intervals computed by logistic regression analyses were not statistically significant. Stratification for the RCC cases according to pathological cell subtype, grade or stage failed to reveal any significant heterogeneity with respect to the genotype of each VEGF polymorphism. We revealed that there are significant ethnic differences in the C702T and G1612A allele frequencies, but suggested that C702T, C936T and G1612A polymorphisms in the 3'-UTR of VEGF gene are not associated with the risk of RCC, at least in Japanese population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12597245     DOI: 10.1620/tjem.198.181

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  14 in total

1.  Lack of association of VEGF gene 3'- UTR polymorphisms (C702T, C936T and G1612A) and the risk of developing advanced retinopathy of prematurity (ROP).

Authors:  Daniela Gismondi; Livja Ndoja; Xianggui Qu; Barkur S Shastry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-07       Impact factor: 3.117

2.  Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.

Authors:  Weifeng Zhong; Xiaohong Wang; Bin Pan; Zexuan Su
Journal:  Tumour Biol       Date:  2014-07-03

3.  Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk.

Authors:  Rihong Zhai; Geoffrey Liu; Kofi Asomaning; Li Su; Matthew H Kulke; Rebecca S Heist; Norman S Nishioka; Thomas J Lynch; John C Wain; Xihong Lin; David C Christiani
Journal:  Carcinogenesis       Date:  2008-09-09       Impact factor: 4.944

4.  The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer.

Authors:  C Yapijakis; E Vairaktaris; S Vassiliou; A Vylliotis; E Nkenke; A M Nixon; S Derka; S Spyridonidou; E Vorris; F Neukam; E Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-13       Impact factor: 4.553

5.  Predictive value of vascular endothelial growth factor polymorphisms on the clinical outcome of renal cell carcinoma patients.

Authors:  Nan Ma; Li-Wei Li; Jing-Liang Cheng
Journal:  Oncol Lett       Date:  2014-12-12       Impact factor: 2.967

6.  An analysis of growth, differentiation and apoptosis genes with risk of renal cancer.

Authors:  Linda M Dong; Paul Brennan; Sara Karami; Rayjean J Hung; Idan Menashe; Sonja I Berndt; Meredith Yeager; Stephen Chanock; David Zaridze; Vsevolod Matveev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Kendra Schwartz; Faith Davis; Marie Navratilova; Neonila Szeszenia-Dabrowska; Dana Mates; Joanne S Colt; Ivana Holcatova; Paolo Boffetta; Nathaniel Rothman; Wong-Ho Chow; Philip S Rosenberg; Lee E Moore
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

Review 7.  The role of vascular endothelial growth factor a polymorphisms in breast cancer.

Authors:  Doonyapat Sa-Nguanraksa; Pornchai O-Charoenrat
Journal:  Int J Mol Sci       Date:  2012-11-13       Impact factor: 5.923

8.  Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer.

Authors:  Su Jin Bae; Dae Ho Ahn; Sung Pyo Hong; Haeyoun Kang; Seong Gyu Hwang; Doyeun Oh; Nam Keun Kim
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

9.  Vascular endothelial growth factor gene polymorphisms and renal cell carcinoma: A systematic review and meta-analysis.

Authors:  Yong Zhang; Sheng Li; Hou-Qin Xiao; Zhao-Xiong Hu; Yan-Cheng Xu; Qi Huang
Journal:  Oncol Lett       Date:  2013-07-29       Impact factor: 2.967

10.  Fetal Vegf Genotype is More Important for Abortion Risk than Mother Genotype.

Authors:  Sinem Atik Yalcintepe; Fatma Silan; Servet Ozden Hacivelioglu; Ahmet Uludag; Emine Cosar; Ozturk Ozdemir
Journal:  Int J Mol Cell Med       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.